TFF Pharmaceuticals (TFFP)
(Delayed Data from NSDQ)
$2.04 USD
-0.14 (-6.42%)
Updated May 23, 2024 03:59 PM ET
After-Market: $2.04 0.00 (0.00%) 5:56 PM ET
2-Buy of 5 2
F Value B Growth B Momentum C VGM
Brokerage Reports
TFF Pharmaceuticals, Inc. [TFFP]
Reports for Purchase
Showing records 141 - 148 ( 148 total )
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Enters CRADA with USAMRIID to Apply TFF Platform to Antibody and Vaccine
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Collaborates with University of Georgia to Pursue Universal Flu Vaccine
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Niclosamide Demonstrates Potential of Thin Film Freezing for COVID-19
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: TFF Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Many Business Development Irons in the Fire, TFF Vori in Phase 1 - 4Q19
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J